BiotechTube
DyAnsys

DyAnsys

San Jose, United States· Est.
dyansys.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $7M

Overview

DyAnsys is a private medical device company founded in 2014, headquartered in San Jose, California, with operational and manufacturing facilities in India. The company's core technology platform centers on the analysis and modulation of the autonomic nervous system (ANS), featuring an FDA-cleared diagnostic device (ANSiscope®) and a wearable auricular neurostimulator for pain management. DyAnsys targets the large and growing digital health markets for chronic pain and ANS diagnostics, positioning its products as safe, affordable, and non-invasive alternatives to pharmaceuticals and invasive procedures. The company appears to be in a commercial, revenue-generating stage, selling its devices to clinicians and hospitals.

Chronic PainPain ManagementDrug Detoxification

Technology Platform

Platform centered on the Autonomic Nervous System (ANS), featuring patented beat-to-beat Heart Rate Variability (HRV) analysis for diagnostics and transcutaneous auricular neurostimulation for therapy.

Funding History

2
Total raised:$7M
Series A$5M
Seed$2M

Opportunities

The global opioid crisis creates a powerful tailwind for non-narcotic, non-invasive pain management solutions like DyAnsys's neurostimulator.
Growing interest in digital health and biomarker-based wellness, specifically HRV, expands the market for its diagnostic ANS measurement technology.

Risk Factors

Clinical adoption risks: The company must generate robust evidence to convince physicians of its neurostimulator's efficacy versus established treatments.
Competitive risks: It operates in crowded markets for pain therapy and wellness diagnostics against larger, well-funded players.
Execution risks: As a private company, scaling global sales, manufacturing, and R&D simultaneously is capital-intensive and challenging.

Competitive Landscape

In pain management, DyAnsys competes with pharmaceutical companies, makers of transcutaneous electrical nerve stimulation (TENS) units, and companies developing invasive and non-invasive neuromodulation devices (e.g., spinal cord stimulators, transcranial magnetic stimulation). In ANS diagnostics, it competes with other medical-grade HRV analysis systems, polygraph devices, and the increasingly sophisticated biometric sensors in consumer wearables (Apple Watch, Whoop, etc.).

More companies in Diagnostics & Precision Medicine →More companies in United States →